← Leaderboards
Isaiah J Fidler
University Of Texas Md Anderson Can Ctr
$5,667,262
Attributed
$5,667,262
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $665.3K · FY2008–12$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$5,667,262 · 6
By mechanism
P30$4,333,797 · 2
P50$873,117 · 3
R35$460,348 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Nora M Navone$4,341,441
- Frank C Marini$3,711,767
- Menashe Bareli$6,643,202
- Yiling Lu$2,887,452
- W K Alfred Yung$11,446,069
Others in their field
Top investigators on “Human Tissue”
- David Heimbrook · Leidos Biomedical Research, Inc.$294,443,261
- Lawrence Corey · Fred Hutchinson Cancer Center$212,638,156
- Larry Arthur$131,303,476
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$114,079,276
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
Research focus
Human TissueImmunocytochemistryIn Situ HybridizationBiomedical FacilityStainingsHistopathologyNeoplastic CellTissue /Cell PreparationGene ExpressionAngiogenesisCell Growth RegulationInterleukin 8ProgramsProstate NeoplasmsOvary NeoplasmsCarcinomaNeoplastic GrowthLaboratory MouseCancer Center Support GrantCancer CenterInterferon BetaAthymic MouseInterferonsMetastasis
Grant awards (23)
Program Leaders$572,131
P30 · FY2012 · CA · contact PI
Program Leaders$2,882
P30 · FY2012 · CA · contact PI
Program Leaders$599,839
P30 · FY2011 · CA · contact PI
Program Leaders$642,799
P30 · FY2010 · CA · contact PI
Program Leaders$665,301
P30 · FY2009 · CA · contact PI
Program Leaders$423,859
P30 · FY2008 · CA · contact PI
CAREER DEVELOPMENT PROGRAM$291,807
P50 · FY2002 · CA
THE BIOLOGY OF HUMAN PROSTATE CANCER METASTASIS$291,807
P50 · FY2002 · CA
Antiangiogenesis therapy of human ovarian cancer$0
P50 · FY2002 · CA
Antiangiogenesis therapy of human ovarian cancer$0
P50 · FY2002 · CA
CORE--CENTRALIZED HISTOPATHOLOGY LABORATORY$0
P30 · FY2002 · CA
CORE--CENTRALIZED HISTOPATHOLOGY LABORATORY$254,104
P30 · FY2001 · CA
CAREER DEVELOPMENT PROGRAM$0
P50 · FY2001 · CA
CORE--CENTRALIZED HISTOPATHOLOGY LABORATORY$0
P30 · FY2001 · CA
CORE--CENTRALIZED HISTOPATHOLOGY LABORATORY$0
P30 · FY2001 · CA
Antiangiogenesis therapy of human ovarian cancer$0
P50 · FY2001 · CA
THE BIOLOGY OF HUMAN PROSTATE CANCER METASTASIS$0
P50 · FY2001 · CA
CANCER METASTASIS--BIOLOGY AND TREATMENT$460,348
R35 · FY2000 · CA
CORE--CENTRALIZED HISTOPATHOLOGY LABORATORY$332,337
P30 · FY2000 · CA
CORE--CENTRALIZED HISTOPATHOLOGY LABORATORY$332,337
P30 · FY2000 · CA
Antiangiogenesis therapy of human ovarian cancer$289,503
P50 · FY2000 · CA
CORE--CENTRALIZED HISTOPATHOLOGY LABORATORY$254,104
P30 · FY2000 · CA
CORE--CENTRALIZED HISTOPATHOLOGY LABORATORY$254,104
P30 · FY2000 · CA